ArticleJACC. Case reports2026
Sudden Cardiac Arrest and Takotsubo-Like Cardiomyopathy as the Initial Presentation of Primary Carnitine Deficiency.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary carnitine deficiency (PCD) is a rare yet treatable disorder of the carnitine cycle causing defective fatty acid oxidation. PCD presents with considerable phenotypic variability, including sudden cardiac death as the initial manifestation. CASE SUMMARY: An 18-year-old female born in India presented with a ventricular fibrillation cardiac arrest. Cardiac evaluation was notable for normal anatomy, nonspecific repolarization changes on electrocardiogram, and cardiac magnetic resonance image showing a Takotsubo-like cardiomyopathy phenotype. Genetic testing identified a homozygous pathogenic variant in SLC22A5 (c.43G>T; p.Gly15Trp) consistent with autosomal recessive PCD. Confirmatory testing demonstrated severely reduced total carnitine levels, which normalized after carnitine supplementation. DISCUSSION: PCD is a rare metabolic condition which can manifest with malignant ventricular arrhythmias. While PCD is routinely detected via the newborn metabolic screen, it should be considered in individuals with cardiac abnormalities who were born internationally. TAKE-HOME MESSAGE: This case highlights malignant ventricular arrhythmia as an initial presentation of PCD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.